Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Tradjenta – Treatment for Type II Diabetes

Drug (Brand / Generic)

Tradjenta / Linagliptin

Company

Boehringer Ingelheim and Eli Lilly

Therapy Class

DPP-4 inhibitor

Current Indication

Type-II diabetes

Market Sector

Diabetes

Current Status

Approved in the US, EU, Japan, Brazil and Mexico
Expand

Go Top